NVZMY Earnings Date: Nov 5, 2026 (Estimated) — Novozymes A/S
OTC · Basic Materials · Specialty Chemicals
Updated
When is NVZMY's next earnings date?
Novozymes A/S (NVZMY) is expected to report earnings on Thursday, November 5, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.76 on revenue of $1.29B.
How did NVZMY do in its last earnings report?
In its most recent report on Aug 20, 2026 (H1 2026), Novozymes A/S posted EPS of $1.27 versus the $0.60 estimate, a beat of 111.7%. Revenue was $2.61B against a $1.27B estimate.
How much does NVZMY stock move after earnings?
NVZMY beat EPS estimates in 2 of its last 4 reported quarters.
About Novozymes A/S
Novozymes A/S is a global biotechnology firm that specializes in the creation and distribution of industrial enzymes, microorganisms, and probiotics. Its operational footprint spans across Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific region. The company's broad range of products caters to numerous sectors: Food and Beverages: Supplying ingredients and processing aids for baking, a variety of beverages, dairy production, starch modification, and protein applications. Household Care: Delivering specialized formulations for laundry, dishwashing, and professional cleaning solutions. Agriculture: Providing innovations for crop cultivation, animal health and nutrition, alongside bioyield and biocontrol products for plant growth. Bioenergy and Industrial Processing: Offering critical components for grain and technical processing, encompassing liquefaction, saccharification, fermentation, fiber conversion, and biomass transformation. Textiles: Featuring technologies for biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing. Pulp and Paper: Enhancing processes through fiber modification, bleach boosting, deposit control, starch modification, and deinking agents. Leather Production: Furnishing treatments for acid bating, area expansion, general bating, degreasing, soaking, and unhairing/liming stages. Water and Waste Management: Contributing with bioaugmentation strategies, optimization of biogas production, and sludge management. Pharmaceuticals: Supplying specialized lipases (both free and immobilized), proteases for biocatalysis, and rTrypsin vital for cell culture applications. Furthermore, Novozymes provides offerings related to human health and various protein-based products. Founded in 1925, Novozymes A/S is headquartered in Bagsvaerd, Denmark.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 | H1 2026 | 0.60 | 1.27 | +111.67% | $2.61B | ✅ Beat | — | — | — |
| 2026-02-25 | FY 2025 | — | 1.73 | — | $4.16B | — | — | — | — |
| 2025-08-21 | H1 2025 | — | 0.88 | — | $2.38B | — | — | — | — |
| 2025-02-26 | FY 2024 | — | 1.39 | — | $4.15B | — | -1.26% | +3.67% | -3.77% |
| 2024-08-27 | H1 2024 | — | 0.69 | — | $2.10B | — | — | — | — |
| 2024-02-01 | Q4 2023 | 0.44 | 0.36 | -18.18% | $664.2M | ❌ Miss | — | — | — |
| 2023-10-26 | Q3 2023 | 0.42 | 0.49 | +16.67% | $650.5M | ✅ Beat | — | — | — |
| 2023-04-26 | Q1 2023 | 0.44 | 0.41 | -6.82% | $666.3M | ❌ Miss | — | — | — |
Showing last 8 quarters.